Electric Therapy Traction Table Market, Global Outlook and Forecast 2023-2029
| Price : US $3250 | Date : May 2023 |
| CAT ID : 7 | Pages : 112 |
The global Humira Biosimilar market was valued at US$ 433.2 million in 2022 and is projected to reach US$ 955.4 million by 2029, at a CAGR of 12.0% during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
The introduction of Humira biosimilars is expected to increase competition in the market, leading to lower prices and improved access to treatment for patients. The availability of biosimilars provides an alternative option for healthcare providers and payers to choose from, potentially reducing the overall healthcare expenditure associated with biologic treatments.
Humira is a tumor necrosis factor (TNF) blocker that reduces the effects of a substance in the body that can cause inflammation.
This report aims to provide a comprehensive presentation of the global market for Humira Biosimilar, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Humira Biosimilar. This report contains market size and forecasts of Humira Biosimilar in global, including the following market information:
Global Humira Biosimilar Market Revenue, 2018-2023, 2024-2029, ($ millions)
Global Humira Biosimilar Market Sales, 2018-2023, 2024-2029, (K Units)
Global top five Humira Biosimilar companies in 2022 (%)
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Humira Biosimilar manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Humira Biosimilar Market, by Type, 2018-2023, 2024-2029 ($ Millions) & (K Units)
Global Humira Biosimilar Market Segment Percentages, by Type, 2022 (%)
Syringe
Pen
Global Humira Biosimilar Market, by Application, 2018-2023, 2024-2029 ($ Millions) & (K Units)
Global Humira Biosimilar Market Segment Percentages, by Application, 2022 (%)
Ankylosing Spondylitis
Rheumatoid Arthritis
Crohn’s Disease
Other
Global Humira Biosimilar Market, By Region and Country, 2018-2023, 2024-2029 ($ Millions) & (K Units)
Global Humira Biosimilar Market Segment Percentages, By Region and Country, 2022 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Humira Biosimilar revenues in global market, 2018-2023 (Estimated), ($ millions)
Key companies Humira Biosimilar revenues share in global market, 2022 (%)
Key companies Humira Biosimilar sales in global market, 2018-2023 (Estimated), (K Units)
Key companies Humira Biosimilar sales share in global market, 2022 (%)
Further, the report presents profiles of competitors in the market, key players include:
Cadila Healthcare
Torrent Pharmaceuticals
Amgen
Boehringer Ingelheim
Novartis
Samsung Bioepis
Viatris
Pfizer
Fresenius Kabi
Coherus
Outline of Major Chapters:
Chapter 1: Introduces the definition of Humira Biosimilar, market overview.
Chapter 2: Global Humira Biosimilar market size in revenue and volume.
Chapter 3: Detailed analysis of Humira Biosimilar manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Humira Biosimilar in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Global Humira Biosimilar capacity by region & country.
Chapter 9: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 10: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 11: The main points and conclusions of the report.
1 Introduction to Research & Analysis Reports
1.1 Humira Biosimilar Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Humira Biosimilar Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Humira Biosimilar Overall Market Size
2.1 Global Humira Biosimilar Market Size: 2022 VS 2029
2.2 Global Humira Biosimilar Revenue, Prospects & Forecasts: 2018-2029
2.3 Global Humira Biosimilar Sales: 2018-2029
3 Company Landscape
3.1 Top Humira Biosimilar Players in Global Market
3.2 Top Global Humira Biosimilar Companies Ranked by Revenue
3.3 Global Humira Biosimilar Revenue by Companies
3.4 Global Humira Biosimilar Sales by Companies
3.5 Global Humira Biosimilar Price by Manufacturer (2018-2023)
3.6 Top 3 and Top 5 Humira Biosimilar Companies in Global Market, by Revenue in 2022
3.7 Global Manufacturers Humira Biosimilar Product Type
3.8 Tier 1, Tier 2 and Tier 3 Humira Biosimilar Players in Global Market
3.8.1 List of Global Tier 1 Humira Biosimilar Companies
3.8.2 List of Global Tier 2 and Tier 3 Humira Biosimilar Companies
4 Sights by Product
4.1 Overview
4.1.1 By Type - Global Humira Biosimilar Market Size Markets, 2022 & 2029
4.1.2 Syringe
4.1.3 Pen
4.2 By Type - Global Humira Biosimilar Revenue & Forecasts
4.2.1 By Type - Global Humira Biosimilar Revenue, 2018-2023
4.2.2 By Type - Global Humira Biosimilar Revenue, 2024-2029
4.2.3 By Type - Global Humira Biosimilar Revenue Market Share, 2018-2029
4.3 By Type - Global Humira Biosimilar Sales & Forecasts
4.3.1 By Type - Global Humira Biosimilar Sales, 2018-2023
4.3.2 By Type - Global Humira Biosimilar Sales, 2024-2029
4.3.3 By Type - Global Humira Biosimilar Sales Market Share, 2018-2029
4.4 By Type - Global Humira Biosimilar Price (Manufacturers Selling Prices), 2018-2029
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Humira Biosimilar Market Size, 2022 & 2029
5.1.2 Ankylosing Spondylitis
5.1.3 Rheumatoid Arthritis
5.1.4 Crohn’s Disease
5.1.5 Other
5.2 By Application - Global Humira Biosimilar Revenue & Forecasts
5.2.1 By Application - Global Humira Biosimilar Revenue, 2018-2023
5.2.2 By Application - Global Humira Biosimilar Revenue, 2024-2029
5.2.3 By Application - Global Humira Biosimilar Revenue Market Share, 2018-2029
5.3 By Application - Global Humira Biosimilar Sales & Forecasts
5.3.1 By Application - Global Humira Biosimilar Sales, 2018-2023
5.3.2 By Application - Global Humira Biosimilar Sales, 2024-2029
5.3.3 By Application - Global Humira Biosimilar Sales Market Share, 2018-2029
5.4 By Application - Global Humira Biosimilar Price (Manufacturers Selling Prices), 2018-2029
6 Sights by Region
6.1 By Region - Global Humira Biosimilar Market Size, 2022 & 2029
6.2 By Region - Global Humira Biosimilar Revenue & Forecasts
6.2.1 By Region - Global Humira Biosimilar Revenue, 2018-2023
6.2.2 By Region - Global Humira Biosimilar Revenue, 2024-2029
6.2.3 By Region - Global Humira Biosimilar Revenue Market Share, 2018-2029
6.3 By Region - Global Humira Biosimilar Sales & Forecasts
6.3.1 By Region - Global Humira Biosimilar Sales, 2018-2023
6.3.2 By Region - Global Humira Biosimilar Sales, 2024-2029
6.3.3 By Region - Global Humira Biosimilar Sales Market Share, 2018-2029
6.4 North America
6.4.1 By Country - North America Humira Biosimilar Revenue, 2018-2029
6.4.2 By Country - North America Humira Biosimilar Sales, 2018-2029
6.4.3 US Humira Biosimilar Market Size, 2018-2029
6.4.4 Canada Humira Biosimilar Market Size, 2018-2029
6.4.5 Mexico Humira Biosimilar Market Size, 2018-2029
6.5 Europe
6.5.1 By Country - Europe Humira Biosimilar Revenue, 2018-2029
6.5.2 By Country - Europe Humira Biosimilar Sales, 2018-2029
6.5.3 Germany Humira Biosimilar Market Size, 2018-2029
6.5.4 France Humira Biosimilar Market Size, 2018-2029
6.5.5 U.K. Humira Biosimilar Market Size, 2018-2029
6.5.6 Italy Humira Biosimilar Market Size, 2018-2029
6.5.7 Russia Humira Biosimilar Market Size, 2018-2029
6.5.8 Nordic Countries Humira Biosimilar Market Size, 2018-2029
6.5.9 Benelux Humira Biosimilar Market Size, 2018-2029
6.6 Asia
6.6.1 By Region - Asia Humira Biosimilar Revenue, 2018-2029
6.6.2 By Region - Asia Humira Biosimilar Sales, 2018-2029
6.6.3 China Humira Biosimilar Market Size, 2018-2029
6.6.4 Japan Humira Biosimilar Market Size, 2018-2029
6.6.5 South Korea Humira Biosimilar Market Size, 2018-2029
6.6.6 Southeast Asia Humira Biosimilar Market Size, 2018-2029
6.6.7 India Humira Biosimilar Market Size, 2018-2029
6.7 South America
6.7.1 By Country - South America Humira Biosimilar Revenue, 2018-2029
6.7.2 By Country - South America Humira Biosimilar Sales, 2018-2029
6.7.3 Brazil Humira Biosimilar Market Size, 2018-2029
6.7.4 Argentina Humira Biosimilar Market Size, 2018-2029
6.8 Middle East & Africa
6.8.1 By Country - Middle East & Africa Humira Biosimilar Revenue, 2018-2029
6.8.2 By Country - Middle East & Africa Humira Biosimilar Sales, 2018-2029
6.8.3 Turkey Humira Biosimilar Market Size, 2018-2029
6.8.4 Israel Humira Biosimilar Market Size, 2018-2029
6.8.5 Saudi Arabia Humira Biosimilar Market Size, 2018-2029
6.8.6 UAE Humira Biosimilar Market Size, 2018-2029
7 Manufacturers & Brands Profiles
7.1 Cadila Healthcare
7.1.1 Cadila Healthcare Company Summary
7.1.2 Cadila Healthcare Business Overview
7.1.3 Cadila Healthcare Humira Biosimilar Major Product Offerings
7.1.4 Cadila Healthcare Humira Biosimilar Sales and Revenue in Global (2018-2023)
7.1.5 Cadila Healthcare Key News & Latest Developments
7.2 Torrent Pharmaceuticals
7.2.1 Torrent Pharmaceuticals Company Summary
7.2.2 Torrent Pharmaceuticals Business Overview
7.2.3 Torrent Pharmaceuticals Humira Biosimilar Major Product Offerings
7.2.4 Torrent Pharmaceuticals Humira Biosimilar Sales and Revenue in Global (2018-2023)
7.2.5 Torrent Pharmaceuticals Key News & Latest Developments
7.3 Amgen
7.3.1 Amgen Company Summary
7.3.2 Amgen Business Overview
7.3.3 Amgen Humira Biosimilar Major Product Offerings
7.3.4 Amgen Humira Biosimilar Sales and Revenue in Global (2018-2023)
7.3.5 Amgen Key News & Latest Developments
7.4 Boehringer Ingelheim
7.4.1 Boehringer Ingelheim Company Summary
7.4.2 Boehringer Ingelheim Business Overview
7.4.3 Boehringer Ingelheim Humira Biosimilar Major Product Offerings
7.4.4 Boehringer Ingelheim Humira Biosimilar Sales and Revenue in Global (2018-2023)
7.4.5 Boehringer Ingelheim Key News & Latest Developments
7.5 Novartis
7.5.1 Novartis Company Summary
7.5.2 Novartis Business Overview
7.5.3 Novartis Humira Biosimilar Major Product Offerings
7.5.4 Novartis Humira Biosimilar Sales and Revenue in Global (2018-2023)
7.5.5 Novartis Key News & Latest Developments
7.6 Samsung Bioepis
7.6.1 Samsung Bioepis Company Summary
7.6.2 Samsung Bioepis Business Overview
7.6.3 Samsung Bioepis Humira Biosimilar Major Product Offerings
7.6.4 Samsung Bioepis Humira Biosimilar Sales and Revenue in Global (2018-2023)
7.6.5 Samsung Bioepis Key News & Latest Developments
7.7 Viatris
7.7.1 Viatris Company Summary
7.7.2 Viatris Business Overview
7.7.3 Viatris Humira Biosimilar Major Product Offerings
7.7.4 Viatris Humira Biosimilar Sales and Revenue in Global (2018-2023)
7.7.5 Viatris Key News & Latest Developments
7.8 Pfizer
7.8.1 Pfizer Company Summary
7.8.2 Pfizer Business Overview
7.8.3 Pfizer Humira Biosimilar Major Product Offerings
7.8.4 Pfizer Humira Biosimilar Sales and Revenue in Global (2018-2023)
7.8.5 Pfizer Key News & Latest Developments
7.9 Fresenius Kabi
7.9.1 Fresenius Kabi Company Summary
7.9.2 Fresenius Kabi Business Overview
7.9.3 Fresenius Kabi Humira Biosimilar Major Product Offerings
7.9.4 Fresenius Kabi Humira Biosimilar Sales and Revenue in Global (2018-2023)
7.9.5 Fresenius Kabi Key News & Latest Developments
7.10 Coherus
7.10.1 Coherus Company Summary
7.10.2 Coherus Business Overview
7.10.3 Coherus Humira Biosimilar Major Product Offerings
7.10.4 Coherus Humira Biosimilar Sales and Revenue in Global (2018-2023)
7.10.5 Coherus Key News & Latest Developments
8 Global Humira Biosimilar Production Capacity, Analysis
8.1 Global Humira Biosimilar Production Capacity, 2018-2029
8.2 Humira Biosimilar Production Capacity of Key Manufacturers in Global Market
8.3 Global Humira Biosimilar Production by Region
9 Key Market Trends, Opportunity, Drivers and Restraints
9.1 Market Opportunities & Trends
9.2 Market Drivers
9.3 Market Restraints
10 Humira Biosimilar Supply Chain Analysis
10.1 Humira Biosimilar Industry Value Chain
10.2 Humira Biosimilar Upstream Market
10.3 Humira Biosimilar Downstream and Clients
10.4 Marketing Channels Analysis
10.4.1 Marketing Channels
10.4.2 Humira Biosimilar Distributors and Sales Agents in Global
11 Conclusion
12 Appendix
12.1 Note
12.2 Examples of Clients
12.3 Disclaimer
LED Light-Up Blanket Market, Global Outlook and Forecast 2023-2029
| Price : US $3250 | Date : May 2023 |
| CAT ID : 7 | Pages : 116 |
Pelvic Floor Functional Magnetic Stimulator Market, Global Outlook and Forecast 2023-2029
| Price : US $3250 | Date : May 2023 |
| CAT ID : 7 | Pages : 115 |
Multi-Modality Biofeedback System Market, Global Outlook and Forecast 2023-2029
| Price : US $3250 | Date : May 2023 |
| CAT ID : 7 | Pages : 112 |
High Frequency Evaluation and Therapy Device Market, Global Outlook and Forecast 2023-2029
| Price : US $3250 | Date : May 2023 |
| CAT ID : 7 | Pages : 115 |
Choose License Type
Why Choose Us ?
24/7 Research support
Quality assurance
Information security
The report efficiently evaluates the market from various dimensions to deliver an
end-product that is informative, elaborate, and accurate and includes detailed
market segmentation, regional analysis, and competitive landscape of the industry.
The report efficiently evaluates the current market size and provides industry forecast.
The market was valued at xx Million US$ in 2019, and is expected to grow at a CAGR of
xx% during the period 2020-2027.
The report efficiently evaluates the current market size and provides forecast for the
industry in terms of Value (US$ Mn) and Volume (Thousands Units).
Market is segmented by Types, Applications, Technology, End-use Industries, and Regions.
The report presents the current market size, and market forecast, market
opportunities, key drivers and restraints, regulatory scenario, industry trend, PESTLE
analysis, PORTER’s analysis, new product approvals/launch, promotion and marketing
initiatives, pricing analysis, competitive landscape which help businesses in
decision making. The analysis data is based on current and historical market trends
which help in investment related decisions.
Custom research is crucial components of the business strategy which helps any
organization to gain insight into specific business sector, aligned with specific area
of interest. Thus, SMI offers more accurate, pragmatic, and actionable information
specifically tailored to suit your business needs.
